Cargando…

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

BACKGROUND: Transarterial chemo-embolisation (TACE) is recommended for patients with BCLC intermediate stage hepatocellular carcinoma (stage B), particularly in patients with good underlying liver function and minimal symptoms. The hepatoma arterial embolisation prognostic (HAP) score combines measu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waked, Imam, Berhane, Sarah, Toyoda, Hidenori, Chan, Stephen L, Stern, Nicholas, Palmer, Daniel, Tada, Toshifumi, Yeo, Winnie, Mo, Frankie, Bettinger, Dominik, Kirstein, Martha M, Iñarrairaegui, Mercedes, Gomaa, Asmaa, Vogel, Arndt, Meyer, Tim, Sangro, Bruno, Lai, Paul, Kumada, Takashi, Johnson, Philip J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318968/ https://www.ncbi.nlm.nih.gov/pubmed/28125820 http://dx.doi.org/10.1038/bjc.2016.423

Ejemplares similares

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’
por: Waked, Iman, et al.
Publicado: (2017)

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
por: Toyoda, Hidenori, et al.
Publicado: (2016)

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’
por: Huo, Teh-Ia, et al.
Publicado: (2017)

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach
por: Han, Guohong, et al.
Publicado: (2020)

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance
por: Johnson, Philip, et al.
Publicado: (2017)

Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular carcinoma
por: Gavriilidis, Paschalis, et al.
Publicado: (2023)

Treatment of hepatic metastases from medullary thyroid cancer with transarterial embolisation
por: Hughes, Peter, et al.
Publicado: (2017)

Transarterial Embolisation of a Gastroduodenal Artery Pseudoaneurysm Rupture Into the Portal Vein
por: Sarkadi, Hunor, et al.
Publicado: (2023)

Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
por: Gomaa, Asmaa Ibrahim, et al.
Publicado: (2014)

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Lawson, Alexander, et al.
Publicado: (2023)

Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience
por: Nawawi, O, et al.
Publicado: (2010)

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
por: Kadalayil, L., et al.
Publicado: (2013)

Haematological risk factors predicting clinical success in transarterial embolisation for acute gastrointestinal bleeding
por: Delf, Jonathan, et al.
Publicado: (2023)

Intermediate stage hepatocellular carcinoma: a summary review
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2020)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
por: Furumaya, Alicia, et al.
Publicado: (2019)

Hepatitis C infection in Egypt: prevalence, impact and management strategies
por: Gomaa, Asmaa, et al.
Publicado: (2017)

Intercostal artery pseudoaneurysm complicating corrosive acid poisoning: Diagnosis with CT and treatment with transarterial embolisation
por: Chalapathi Rao, MV, et al.
Publicado: (2014)

Transarterial embolisation is associated with improved survival in patients with pelvic fracture: propensity score matching analyses
por: Kim, Hohyun, et al.
Publicado: (2020)

Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan
por: Toyoda, Hidenori, et al.
Publicado: (2011)

Progression of liver fibrosis is associated with non‐liver‐related mortality in patients with nonalcoholic fatty liver disease
por: Tada, Toshifumi, et al.
Publicado: (2017)

Safety, feasibility, and comfort of hepatic angiography and transarterial intervention with radial access for hepatocellular carcinoma
por: Toyoda, Hidenori, et al.
Publicado: (2021)

Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead
por: Reicher, John, et al.
Publicado: (2019)

Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy
por: Toyoda, Hidenori, et al.
Publicado: (2014)

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus
por: Tachi, Yoshihiko, et al.
Publicado: (2015)

Natural history of liver‐related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model
por: Tada, Toshifumi, et al.
Publicado: (2019)

Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus
por: Kumada, Takashi, et al.
Publicado: (2021)

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
por: Elshaarawy, Omar, et al.
Publicado: (2019)

High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma
por: Kumada, Takashi, et al.
Publicado: (2013)

Long- and short-term outcomes of ERCP for bile duct stones in patients over 80 years old compared to younger patients: a propensity score analysis
por: Kanamori, Akira, et al.
Publicado: (2016)

Differences in the impact of prognostic factors for hepatocellular carcinoma over time
por: Toyoda, Hidenori, et al.
Publicado: (2017)

Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus
por: Kumada, Takashi, et al.
Publicado: (2021)

Hepatitis C in Egypt – past, present, and future
por: Elgharably, Ahmed, et al.
Publicado: (2016)

Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib
por: Sangro, Bruno, et al.
Publicado: (2012)

Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres: preclinical assessment in a human isolated lung perfusion model
por: Schaarschmidt, Benedikt M., et al.
Publicado: (2022)

Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases
por: Fohlen, Audrey, et al.
Publicado: (2023)

Uterine Artery Embolisation of Fibroids and the Phenomenon of Post-Embolisation Syndrome: A Systematic Review
por: Waldron, Michael G., et al.
Publicado: (2022)

Role of hepatic resection in patients with intermediate‐stage hepatocellular carcinoma: A multicenter study from Japan
por: Tada, Toshifumi, et al.
Publicado: (2017)

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
por: Meyer, T, et al.
Publicado: (2013)

Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study
por: Bessar, Ahmed A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r07fgq4p98vmah2ro2qdl5g6s6